查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1821597

2025年真實世界證據解決方案全球市場報告

Real World Evidence Solutions Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年真實世界證據解決方案市場將快速成長，到2029年將達到41.8億美元，年複合成長率（CAGR）為15.7%。預測期內的成長動力來自以下因素：針對特定治療領域的客製化RWE解決方案、真實世界資料網路的擴展、真實世界證據生成領域的創新、RWE在藥物開發和獲取中的應用，以及醫療保健和技術領域之間的合作。預測期內的主要趨勢包括：人工智慧驅動的RWE預測分析、RWE資料隱私和安全的合規性、醫療保健提供者的個人化RWE解決方案、資料共用和RWE結果的透明度，以及RWE在藥品定價和報銷中的整合。

未來五年15.7%的成長率預測比我們先前的預測略有下降0.2%。這一下降主要源自於美國與其他國家之間關稅的影響。徵收關稅可能會擾亂美國的健康分析，因為這會增加以色列和愛沙尼亞開發的人工智慧患者資料聚合平台的成本，削弱上市後監管，並可能增加藥物安全檢測支出。由於互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響，關稅的影響可能更為廣泛。

預計老年人口的成長將推動真實世界證據解決方案市場的成長。老年人口（定義為 65 歲及以上的人群）患各種問題的風險更高，包括姿勢性低血壓、平衡障礙和步態障礙。老齡化也會增加中風、心血管疾病、2 型糖尿病、關節炎和癌症等慢性疾病的風險。例如，根據美國非營利組織人口研究所發布的數據，預計 2050 年美國65 歲及以上人口將增加 47%，從 2022 年的 5,800 萬增加到 8,200 萬人。此外，他們在總人口中的比例預計將從 17% 增加到 23%。因此，老年人口的擴大是真實世界證據解決方案市場的主要驅動力。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球現實世界證據解決方案：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球真實世界證據解決方案市場：成長率分析
  • 全球真實世界證據解決方案市場表現：規模與成長，2019-2024
  • 全球真實世界證據解決方案市場預測：規模與成長，2024-2029 年，2034 年
  • 全球真實世界證據解決方案：總可尋址市場 (TAM)

第6章 市場細分

  • 全球真實世界證據解決方案市場：按組成部分、實際和預測，2019-2024 年、2024-2029 年、2034 年
  • 服務
  • 資料集
  • 臨床環境數據
  • 帳單數據
  • 藥房數據
  • 患者主導數據
  • 全球真實世界證據解決方案市場：按治療領域、實際和預測，2019-2024 年、2024-2029 年、2034 年
  • 腫瘤學
  • 心血管系統
  • 神經病學
  • 免疫學
  • 其他治療領域
  • 全球真實世界證據解決方案市場：按應用、效能和預測，2019-2024 年、2024-2029 年、2034 年
  • 藥物研發與核准
  • 醫療設備開發與核准
  • 報銷/覆蓋範圍和監管決策
  • 上市後安全性與不利事件監測
  • 全球真實世界證據解決方案市場：按最終用戶、實際和預測，2019-2024 年、2024-2029 年、2034 年
  • 製藥和醫療設備公司
  • 醫療保健提供者
  • 醫療保健付款人
  • 其他最終用戶
  • 全球真實世界證據解決方案市場：按服務類型、績效和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 諮詢服務
  • 資料管理服務
  • 監管服務
  • 分析服務
  • 全球真實世界證據解決方案市場：按資料集類型、實際和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 電子健康紀錄（EHR）
  • 病人登記
  • 臨床試驗數據
  • 觀察性研究數據
  • 全球真實世界證據解決方案市場：依臨床即時診斷資料類型細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院數據
  • 門診病人數據
  • 專業護理數據
  • 帳單數據
  • 全球真實世界證據解決方案市場：按保險索賠資料類型細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 醫療保險/醫療補助數據
  • 商業索賠數據
  • 藥房數據
  • 全球真實世界證據解決方案市場：細分處方箋資料（按類型）、實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 藥房索賠數據
  • 藥物使用數據
  • 全球真實世界證據解決方案市場：按患者主導資料類型細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 患者調查
  • 患者報告結果（PRO）
  • 穿戴式裝置數據

第7章 區域和國家分析

  • 全球真實世界證據解決方案市場：區域表現與預測，2019-2024 年、2024-2029 年、2034 年
  • 全球真實世界證據解決方案市場：國家、績效與預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 真實世界證據解決方案市場：競爭格局
  • 真實世界證據解決方案市場：公司簡介
    • Anthem Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Cegedim Health Data Overview, Products and Services, Strategy and Financial Analysis
    • Clarivate PLC Overview, Products and Services, Strategy and Financial Analysis
    • Clinigen Group Overview, Products and Services, Strategy and Financial Analysis
    • Cognizant Technology Solutions Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Flatiron Health Inc.
  • International Business Machines Corporation
  • ICON plc
  • IQVIA Holdings Inc.
  • Medpace Holdings Inc.
  • Optum Inc.
  • Oracle Corporation
  • PAREXEL International Corporation
  • PerkinElmer Inc.
  • PPD Inc.
  • SAS Institute Inc.
  • Syneos Health
  • Symphony Innovation LLC
  • UnitedHealth Group Incorporated
  • Amerisource Bergen Corporation

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029 年真實世界證據解決方案市場：提供新機會的國家
  • 2029 年真實世界證據解決方案市場：細分市場帶來新機會
  • 2029 年真實世界證據解決方案市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r22011u

Real-world evidence (RWE) refers to clinical insights obtained from data collected outside of controlled clinical trials. This data can come from various sources, including electronic health records, insurance claims, and patient registries. RWE is valuable for evaluating the safety, effectiveness, and usage of medical treatments in real-world healthcare settings.

Key components of real-world evidence solutions include services, data sets, clinical setting data, claims data, pharmacy data, and patient-powered data. Services encompass activities or tasks performed with a commercial purpose and find application in various therapeutic areas such as oncology, cardiovascular disease, neurology, immunology, and others. These solutions are employed in critical processes such as drug development and approval, medical device development and approval, reimbursement/coverage and regulatory decision-making, as well as post-market safety and adverse event monitoring. End-users of real-world evidence solutions include pharmaceutical and medical device companies, healthcare providers, healthcare payers, and other entities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The real world evidence solutions market research report is one of a series of new reports from The Business Research Company that provides real world evidence solutions market statistics, including real world evidence solutions industry global market size, regional shares, competitors with a real world evidence solutions market share, detailed real world evidence solutions market segments, market trends and opportunities, and any further data you may need to thrive in the real world evidence solutions industry. This real-world evidence solutions market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The real world evidence solutions market size has grown rapidly in recent years. It will grow from $2.03 billion in 2024 to $2.33 billion in 2025 at a compound annual growth rate (CAGR) of 14.5%. The growth in the historic period can be attributed to growth in pharmaceutical and healthcare sectors, demand for post-market surveillance and drug safety, expansion of electronic health records and data, adoption in clinical research and outcomes assessment, regulatory standards for real-world evidence (rwe).

The real world evidence solutions market size is expected to see rapid growth in the next few years. It will grow to $4.18 billion in 2029 at a compound annual growth rate (CAGR) of 15.7%. The growth in the forecast period can be attributed to customized rwe solutions for specificTherapeutic areas, expansion of real-world data networks, innovation in real-world evidence generation, adoption of rwe in drug development and access, collaboration between healthcare and technology sectors. Major trends in the forecast period include ai-driven predictive analytics in rwe, regulatory compliance in rwe data privacy and security, personalized rwe solutions for healthcare providers, transparency in data sharing and rwe findings, integration of rwe in drug pricing and reimbursement.

The forecast of 15.7% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. health analytics by increasing costs for Artificial intelligence-powered patient data aggregation platforms developed in Israel and Estonia, potentially compromising post-market surveillance and raising pharmacovigilance expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing geriatric population is anticipated to drive the growth of the real-world evidence solutions market. The geriatric population, defined as individuals aged 65 and older, is at a higher risk for various issues, including postural hypotension and balance or gait impairments. Aging also heightens the risk of chronic diseases such as strokes, cardiovascular conditions, type 2 diabetes, arthritis, and cancer. For instance, data published by the Population Reference Bureau, a nonprofit organization based in the U.S., indicates that the population of Americans aged 65 and older is projected to rise from 58 million in 2022 to 82 million by 2050, representing a 47% increase. Furthermore, their proportion of the total population is expected to grow from 17% to 23%. Consequently, the expanding geriatric population is a key driver of the real-world evidence solutions market.

Government support is poised to play a crucial role in propelling the growth of the real-world evidence solutions market in the future. Increased government initiatives aimed at enhancing public awareness and understanding of real-world evidence solutions have a positive impact on the overall market expansion. Government backing creates a conducive environment for the adoption and growth of real-world evidence solutions in the healthcare industry. This support empowers healthcare providers and pharmaceutical companies to make more informed decisions concerning patient care and drug development. Notably, in February 2023, the UK government pledged increased investment with a specific focus on entities responsible for approving medical devices and ensuring compliance with new regulatory requirements. Additionally, the Romanian government, in June 2022, launched the National Agency for Health Infrastructure Development to bring more coherence to investments in health infrastructure. Thus, government support is expected to contribute significantly to the growth of the real-world evidence solutions market.

The advancement of real-world evidence has emerged as a significant trend in the real-world evidence market. The ability to achieve commercial success and facilitate informed decision-making through real-world data is increasingly important, and real-world evidence effectively meets the demand for additional insights. For example, in May 2023, Inspire, a data infrastructure and analytics company based in the U.S., introduced its Real-World Evidence (RWE) solutions. Inspire RWE provides innovative data and analytics tools for life sciences companies, utilizing its patient engagement platform to collect real-world insights from millions of patients, with the goal of enhancing patient-centered healthcare outcomes.

Major companies in the real-world evidence solutions market are actively developing innovative products, such as the introduction of a new Real-World Evidence (RWE) Solutions service designed to optimize evidence-based medicine. Real-World Evidence Solutions services aim to generate and analyze clinical evidence on the usage, potential benefits, and risks of medical products using real-world data (RWD) derived from routine healthcare delivery. For instance, in October 2023, Maxis Clinical Sciences launched a new Real-World Evidence (RWE) Solutions service, combining various RWD sources, including patient-reported outcomes and data from wearable devices, to enhance patient participation and data quality.

In October 2022, Cegedim SA, a software company based in France, acquired Clinityx for an undisclosed amount. This acquisition bolsters Cegedim's Real-World Data portfolio, furthering its objective to become a leader in Europe's real-world health data market by enhancing its data-driven healthcare solutions. Clinityx, also based in France, specializes in health data and real-world data solutions.

Major companies operating in the real world evidence solutions market include Anthem Inc., Cegedim Health Data, Clarivate PLC, Clinigen Group, Cognizant Technology Solutions Corporation, Flatiron Health Inc., International Business Machines Corporation, ICON plc, IQVIA Holdings Inc., Medpace Holdings Inc., Optum Inc., Oracle Corporation, PAREXEL International Corporation, PerkinElmer Inc., PPD Inc., SAS Institute Inc., Syneos Health, Symphony Innovation LLC, UnitedHealth Group Incorporated, Amerisource Bergen Corporation, Cardinal Health, Deloitte Touche Tohmatsu Limited, Informa PLC, Palantir Technologies, UDG Healthcare PLC, Thermo Fisher Scientific Inc., Elevance Health Inc., Covance Consulting Ltd., Clinipace Worldwide, Evidera Inc., Pharmerit International, Analysis Group Inc., HealthCore Inc., Inovalon Holdings Inc., KMK Consulting Inc.

North America was the largest region in the real world evidence solutions market in 2024. Asia-Pacific is expected to be the fastest-growing region in the real world evidence solutions market share during the forecast period. The regions covered in the real-world evidence solutions market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the real-world evidence solutions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The real-world evidence solutions market consists of sales of solutions that are used in randomized trials, large simple trials, pragmatic trials, and observational studies. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Real World Evidence Solutions Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on real world evidence solutions market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for real world evidence solutions ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The real world evidence solutions market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Component: Services; Data Sets; Clinical Setting Data; Claims Data; Pharmacy Data; Patient Powered Data
  • 2) By Therapeutic Area: Oncology; Cardiovascular; Neurology; Immunology; Other Therapeutic Areas
  • 3) By Application: Drug Development And Approvals; Medical Device Development And Approvals; Reimbursement/Coverage And Regulatory Decision Making; Post Market Safety And Adverse Events Monitoring
  • 4) By End-Users: Pharmaceutical And Medical Devices Companies; Healthcare Providers; Healthcare Payers; Other End-Users
  • Subsegments:
  • 1) By Services: Consulting Services; Data Management Services; Regulatory Services; Analytics Services
  • 2) By Data Sets: Electronic Health Records (EHR); Patient Registries; Clinical Trials Data; Observational Study Data
  • 3) By Clinical Setting Data: Hospital Data; Outpatient Data; Specialty Care Data; Claims Data
  • 4) By Insurance Claims Data: Medicare/Medicaid Data; Commercial Claims Data; Pharmacy Data
  • 5) By Prescription Data: Pharmacy Claims Data; Drug Utilization Data
  • 6) By Patient Powered Data: Patient Surveys; Patient-Reported Outcomes (PRO); Wearable Device Data
  • Companies Mentioned: Anthem Inc.; Cegedim Health Data; Clarivate PLC; Clinigen Group; Cognizant Technology Solutions Corporation; Flatiron Health Inc.; International Business Machines Corporation; ICON plc; IQVIA Holdings Inc.; Medpace Holdings Inc.; Optum Inc.; Oracle Corporation; PAREXEL International Corporation; PerkinElmer Inc.; PPD Inc.; SAS Institute Inc.; Syneos Health; Symphony Innovation LLC; UnitedHealth Group Incorporated; Amerisource Bergen Corporation; Cardinal Health; Deloitte Touche Tohmatsu Limited; Informa PLC; Palantir Technologies; UDG Healthcare PLC; Thermo Fisher Scientific Inc.; Elevance Health Inc.; Covance Consulting Ltd.; Clinipace Worldwide; Evidera Inc.; Pharmerit International; Analysis Group Inc.; HealthCore Inc.; Inovalon Holdings Inc.; KMK Consulting Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Real World Evidence Solutions Market Characteristics

3. Real World Evidence Solutions Market Trends And Strategies

4. Real World Evidence Solutions Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Real World Evidence Solutions Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Real World Evidence Solutions PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Real World Evidence Solutions Market Growth Rate Analysis
  • 5.4. Global Real World Evidence Solutions Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Real World Evidence Solutions Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Real World Evidence Solutions Total Addressable Market (TAM)

6. Real World Evidence Solutions Market Segmentation

  • 6.1. Global Real World Evidence Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Services
  • Data Sets
  • Clinical Setting Data
  • Claims Data
  • Pharmacy Data
  • Patient Powered Data
  • 6.2. Global Real World Evidence Solutions Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oncology
  • Cardiovascular
  • Neurology
  • Immunology
  • Other Therapeutic Areas
  • 6.3. Global Real World Evidence Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug Development And Approvals
  • Medical Device Development And Approvals
  • Reimbursement/Coverage And Regulatory Decision Making
  • Post Market Safety And Adverse Events Monitoring
  • 6.4. Global Real World Evidence Solutions Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharmaceutical And Medical Devices Companies
  • Healthcare Providers
  • Healthcare Payers
  • Other End-Users
  • 6.5. Global Real World Evidence Solutions Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Consulting Services
  • Data Management Services
  • Regulatory Services
  • Analytics Services
  • 6.6. Global Real World Evidence Solutions Market, Sub-Segmentation Of Data Sets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Electronic Health Records (EHR)
  • Patient Registries
  • Clinical Trials Data
  • Observational Study Data
  • 6.7. Global Real World Evidence Solutions Market, Sub-Segmentation Of Clinical Setting Data, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital Data
  • Outpatient Data
  • Specialty Care Data
  • Claims Data
  • 6.8. Global Real World Evidence Solutions Market, Sub-Segmentation Of Insurance Claims Data, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Medicare/Medicaid Data
  • Commercial Claims Data
  • Pharmacy Data
  • 6.9. Global Real World Evidence Solutions Market, Sub-Segmentation Of Prescription Data, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharmacy Claims Data
  • Drug Utilization Data
  • 6.10. Global Real World Evidence Solutions Market, Sub-Segmentation Of Patient Powered Data, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Patient Surveys
  • Patient-Reported Outcomes (PRO)
  • Wearable Device Data

7. Real World Evidence Solutions Market Regional And Country Analysis

  • 7.1. Global Real World Evidence Solutions Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Real World Evidence Solutions Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Real World Evidence Solutions Market

  • 8.1. Asia-Pacific Real World Evidence Solutions Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Real World Evidence Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Real World Evidence Solutions Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Real World Evidence Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Real World Evidence Solutions Market

  • 9.1. China Real World Evidence Solutions Market Overview
  • 9.2. China Real World Evidence Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Real World Evidence Solutions Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Real World Evidence Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Real World Evidence Solutions Market

  • 10.1. India Real World Evidence Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Real World Evidence Solutions Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Real World Evidence Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Real World Evidence Solutions Market

  • 11.1. Japan Real World Evidence Solutions Market Overview
  • 11.2. Japan Real World Evidence Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Real World Evidence Solutions Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Real World Evidence Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Real World Evidence Solutions Market

  • 12.1. Australia Real World Evidence Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Real World Evidence Solutions Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Real World Evidence Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Real World Evidence Solutions Market

  • 13.1. Indonesia Real World Evidence Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Real World Evidence Solutions Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Real World Evidence Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Real World Evidence Solutions Market

  • 14.1. South Korea Real World Evidence Solutions Market Overview
  • 14.2. South Korea Real World Evidence Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Real World Evidence Solutions Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Real World Evidence Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Real World Evidence Solutions Market

  • 15.1. Western Europe Real World Evidence Solutions Market Overview
  • 15.2. Western Europe Real World Evidence Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Real World Evidence Solutions Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Real World Evidence Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Real World Evidence Solutions Market

  • 16.1. UK Real World Evidence Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Real World Evidence Solutions Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Real World Evidence Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Real World Evidence Solutions Market

  • 17.1. Germany Real World Evidence Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Real World Evidence Solutions Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Real World Evidence Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Real World Evidence Solutions Market

  • 18.1. France Real World Evidence Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Real World Evidence Solutions Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Real World Evidence Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Real World Evidence Solutions Market

  • 19.1. Italy Real World Evidence Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Real World Evidence Solutions Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Real World Evidence Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Real World Evidence Solutions Market

  • 20.1. Spain Real World Evidence Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Real World Evidence Solutions Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Real World Evidence Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Real World Evidence Solutions Market

  • 21.1. Eastern Europe Real World Evidence Solutions Market Overview
  • 21.2. Eastern Europe Real World Evidence Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Real World Evidence Solutions Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Real World Evidence Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Real World Evidence Solutions Market

  • 22.1. Russia Real World Evidence Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Real World Evidence Solutions Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Real World Evidence Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Real World Evidence Solutions Market

  • 23.1. North America Real World Evidence Solutions Market Overview
  • 23.2. North America Real World Evidence Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Real World Evidence Solutions Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Real World Evidence Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Real World Evidence Solutions Market

  • 24.1. USA Real World Evidence Solutions Market Overview
  • 24.2. USA Real World Evidence Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Real World Evidence Solutions Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Real World Evidence Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Real World Evidence Solutions Market

  • 25.1. Canada Real World Evidence Solutions Market Overview
  • 25.2. Canada Real World Evidence Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Real World Evidence Solutions Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Real World Evidence Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Real World Evidence Solutions Market

  • 26.1. South America Real World Evidence Solutions Market Overview
  • 26.2. South America Real World Evidence Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Real World Evidence Solutions Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Real World Evidence Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Real World Evidence Solutions Market

  • 27.1. Brazil Real World Evidence Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Real World Evidence Solutions Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Real World Evidence Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Real World Evidence Solutions Market

  • 28.1. Middle East Real World Evidence Solutions Market Overview
  • 28.2. Middle East Real World Evidence Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Real World Evidence Solutions Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Real World Evidence Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Real World Evidence Solutions Market

  • 29.1. Africa Real World Evidence Solutions Market Overview
  • 29.2. Africa Real World Evidence Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Real World Evidence Solutions Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Real World Evidence Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Real World Evidence Solutions Market Competitive Landscape And Company Profiles

  • 30.1. Real World Evidence Solutions Market Competitive Landscape
  • 30.2. Real World Evidence Solutions Market Company Profiles
    • 30.2.1. Anthem Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Cegedim Health Data Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Clarivate PLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Clinigen Group Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Cognizant Technology Solutions Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Real World Evidence Solutions Market Other Major And Innovative Companies

  • 31.1. Flatiron Health Inc.
  • 31.2. International Business Machines Corporation
  • 31.3. ICON plc
  • 31.4. IQVIA Holdings Inc.
  • 31.5. Medpace Holdings Inc.
  • 31.6. Optum Inc.
  • 31.7. Oracle Corporation
  • 31.8. PAREXEL International Corporation
  • 31.9. PerkinElmer Inc.
  • 31.10. PPD Inc.
  • 31.11. SAS Institute Inc.
  • 31.12. Syneos Health
  • 31.13. Symphony Innovation LLC
  • 31.14. UnitedHealth Group Incorporated
  • 31.15. Amerisource Bergen Corporation

32. Global Real World Evidence Solutions Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Real World Evidence Solutions Market

34. Recent Developments In The Real World Evidence Solutions Market

35. Real World Evidence Solutions Market High Potential Countries, Segments and Strategies

  • 35.1 Real World Evidence Solutions Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Real World Evidence Solutions Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Real World Evidence Solutions Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer